Literature DB >> 15508579

Differential expression of the isoforms of human vascular endothelial growth factor and new approaches to therapeutic angiogenesis.

K G Skryabin1, M A El'darov, D K Kamardinov, M V Zinov'eva, D S Ivanov, V S Prasolov, S T Matskeplishvili, Iu I Busiashvili, R V Petrov, L A Bokeriia, M P Kirpichnikov.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15508579     DOI: 10.1023/b:dobs.0000039697.90040.25

Source DB:  PubMed          Journal:  Dokl Biol Sci        ISSN: 0012-4966


× No keyword cloud information.
  13 in total

Review 1.  Myocardial replacement therapy.

Authors:  Tomasz Siminiak; Maciej Kurpisz
Journal:  Circulation       Date:  2003-09-09       Impact factor: 29.690

2.  Strategy of complete revascularization in patients with multivessel coronary artery disease (a report from the 1985-1986 NHLBI PTCA Registry).

Authors:  M G Bourassa; R Holubkov; W Yeh; K M Detre
Journal:  Am J Cardiol       Date:  1992-07-15       Impact factor: 2.778

Review 3.  Atherosclerosis and angiogenesis. Its pathophysiological significance in humans as well as in an animal model induced by the gene transfer of vascular endothelial growth factor.

Authors:  K Sueishi; Y Yonemitsu; K Nakagawa; Y Kaneda; M Kumamoto; Y Nakashima
Journal:  Ann N Y Acad Sci       Date:  1997-04-15       Impact factor: 5.691

4.  Induction of angiogenesis in a mouse model using engineered transcription factors.

Authors:  Edward J Rebar; Yan Huang; Reed Hickey; Anjali K Nath; David Meoli; Sameer Nath; Bingliang Chen; Lei Xu; Yuxin Liang; Andrew C Jamieson; Lei Zhang; S Kaye Spratt; Casey C Case; Alan Wolffe; Frank J Giordano
Journal:  Nat Med       Date:  2002-11-04       Impact factor: 53.440

Review 5.  VEGF gene delivery for treatment of ischemic cardiovascular disease.

Authors:  Mark L Koransky; Robert C Robbins; Helen M Blau
Journal:  Trends Cardiovasc Med       Date:  2002-04       Impact factor: 6.677

6.  Angiogenesis gene therapy: phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease.

Authors:  T K Rosengart; L Y Lee; S R Patel; T A Sanborn; M Parikh; G W Bergman; R Hachamovitch; M Szulc; P D Kligfield; P M Okin; R T Hahn; R B Devereux; M R Post; N R Hackett; T Foster; T M Grasso; M L Lesser; O W Isom; R G Crystal
Journal:  Circulation       Date:  1999-08-03       Impact factor: 29.690

Review 7.  Management of chronic stable angina: medical therapy, percutaneous transluminal coronary angioplasty, and coronary artery bypass graft surgery. Lessons from the randomized trials.

Authors:  A J Solomon; B J Gersh
Journal:  Ann Intern Med       Date:  1998-02-01       Impact factor: 25.391

8.  [Prospects for gene therapy of cardiovascular diseases].

Authors:  E V Parfenova; V A Tkachuk
Journal:  Vopr Med Khim       Date:  2000 May-Jun

Review 9.  Vascular endothelial growth factor (VEGF) and its receptors.

Authors:  G Neufeld; T Cohen; S Gengrinovitch; Z Poltorak
Journal:  FASEB J       Date:  1999-01       Impact factor: 5.191

Review 10.  Recent insights into coronary collateral circulation.

Authors:  S Sasayama; M Fujita
Journal:  Circulation       Date:  1992-03       Impact factor: 29.690

View more
  1 in total

1.  Coordinated vascular endothelial growth factor expression and signaling during skeletal myogenic differentiation.

Authors:  Brad A Bryan; Tony E Walshe; Dianne C Mitchell; Josh S Havumaki; Magali Saint-Geniez; Arindel S Maharaj; Angel E Maldonado; Patricia A D'Amore
Journal:  Mol Biol Cell       Date:  2007-12-19       Impact factor: 4.138

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.